Skip to main content
NVDA0.00%AAPL-0.15%GOOGL+0.59%MSFT+0.03%AMZN+0.01%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.09%TSLA+0.10%SKHY-5.20%MU+0.04%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ORCL-5.23%ABBV+1.62%BAC-0.18%CSCO-1.82%CVX-0.50%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%UNH-1.22%HSBA.L-1.30%DELL-5.35%PG+0.25%MS-1.22%GE-0.39%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.58%AUDJPY-1.80%CHFJPY-1.60%NZDCAD-1.45%NZDUSD-1.44%EURNZD+1.43%GBPNZD+1.39%GBPJPY-1.21%EURJPY-1.20%USDJPY-1.17%CADJPY-1.15%NZDCHF-1.02%USDZAR+0.99%USDSEK+0.98%USDNOK+0.86%AUDNZD+0.81%EURZAR+0.79%EURSEK+0.77%USDTHB+0.72%GBPZAR+0.72%AUDCAD-0.68%EURNOK+0.65%AUDUSD-0.64%AUDDKK-0.63%EURAUD+0.61%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.58%AUDSGD-0.54%USDPLN+0.49%CHFNOK+0.47%USDCHF+0.44%CADCHF+0.44%NZDSGD-0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.38%GBPHKD+0.32%USDSGD+0.29%NOKJPY-0.29%GBPMXN-0.28%EURPLN+0.28%SGDJPY+0.27%EURHKD-0.21%USDDKK+0.21%AUDCHF-0.20%USDILS+0.16%NZDMXN-0.15%USDTRY+0.11%USDCNH+0.10%CHFSGD-0.09%EURSGD+0.09%PLNJPY+0.08%EURCNH-0.08%GBPCAD-0.07%EURCAD-0.05%GBPUSD-0.04%USDCOP-0.04%EURUSD-0.04%EURCZK-0.03%EURGBP+0.03%AUDNOK+0.02%GBPSGD+0.02%USDHKD+0.02%USDCAD-0.01%EURDKK+0.01%UKOIL+6.50%USOIL+6.43%XPTUSD-6.23%GAGUSD-5.47%XAGUSD-5.47%HG1-4.75%XAUUSD-1.91%GAUUSD-1.91%XNGUSD+1.68%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.33%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-2.96%SOLUSD-1.53%TRXUSDT+0.12%ZECUSDT-9.23%DOGEUSD-2.23%XMRUSDT-0.01%LINKUSD-1.60%XLMUSD-1.73%BCHUSDT-9.67%LTCUSD-1.56%UNIUSD-1.38%TONUSD+24.88%HBARUSDT-1.83%SUIUSD-3.97%TAOUSDT-5.64%AAVEUSD-2.20%DOTUSDT-1.47%ICPUSDT+1.37%ONDOUSDT-3.29%WLDUSDT-2.91%ATOMUSDT-2.11%ARBUSDT-1.80%JUPUSDT-2.75%INJUSDT-2.57%STXUSDT-4.53%FETUSDT-2.39%TIAUSDT-1.13%PYTHUSDT-1.18%SEIUSDT-6.02%IMXUSDT-3.06%WIFUSDT-4.89%GRTUSDT-3.39%OPUSDT-3.00%POLUSDT-4.79%IOTAUSDT-4.19%AXSUSDT-2.25%FARTCOINUSDT-3.27%EOSUSDT-2.41%DYDXUSDT-1.79%ORDIUSDT-0.96%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA0.00%AAPL-0.15%GOOGL+0.59%MSFT+0.03%AMZN+0.01%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.09%TSLA+0.10%SKHY-5.20%MU+0.04%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ORCL-5.23%ABBV+1.62%BAC-0.18%CSCO-1.82%CVX-0.50%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%UNH-1.22%HSBA.L-1.30%DELL-5.35%PG+0.25%MS-1.22%GE-0.39%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.58%AUDJPY-1.80%CHFJPY-1.60%NZDCAD-1.45%NZDUSD-1.44%EURNZD+1.43%GBPNZD+1.39%GBPJPY-1.21%EURJPY-1.20%USDJPY-1.17%CADJPY-1.15%NZDCHF-1.02%USDZAR+0.99%USDSEK+0.98%USDNOK+0.86%AUDNZD+0.81%EURZAR+0.79%EURSEK+0.77%USDTHB+0.72%GBPZAR+0.72%AUDCAD-0.68%EURNOK+0.65%AUDUSD-0.64%AUDDKK-0.63%EURAUD+0.61%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.58%AUDSGD-0.54%USDPLN+0.49%CHFNOK+0.47%USDCHF+0.44%CADCHF+0.44%NZDSGD-0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.38%GBPHKD+0.32%USDSGD+0.29%NOKJPY-0.29%GBPMXN-0.28%EURPLN+0.28%SGDJPY+0.27%EURHKD-0.21%USDDKK+0.21%AUDCHF-0.20%USDILS+0.16%NZDMXN-0.15%USDTRY+0.11%USDCNH+0.10%CHFSGD-0.09%EURSGD+0.09%PLNJPY+0.08%EURCNH-0.08%GBPCAD-0.07%EURCAD-0.05%GBPUSD-0.04%USDCOP-0.04%EURUSD-0.04%EURCZK-0.03%EURGBP+0.03%AUDNOK+0.02%GBPSGD+0.02%USDHKD+0.02%USDCAD-0.01%EURDKK+0.01%UKOIL+6.50%USOIL+6.43%XPTUSD-6.23%GAGUSD-5.47%XAGUSD-5.47%HG1-4.75%XAUUSD-1.91%GAUUSD-1.91%XNGUSD+1.68%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.33%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-2.96%SOLUSD-1.53%TRXUSDT+0.12%ZECUSDT-9.23%DOGEUSD-2.23%XMRUSDT-0.01%LINKUSD-1.60%XLMUSD-1.73%BCHUSDT-9.67%LTCUSD-1.56%UNIUSD-1.38%TONUSD+24.88%HBARUSDT-1.83%SUIUSD-3.97%TAOUSDT-5.64%AAVEUSD-2.20%DOTUSDT-1.47%ICPUSDT+1.37%ONDOUSDT-3.29%WLDUSDT-2.91%ATOMUSDT-2.11%ARBUSDT-1.80%JUPUSDT-2.75%INJUSDT-2.57%STXUSDT-4.53%FETUSDT-2.39%TIAUSDT-1.13%PYTHUSDT-1.18%SEIUSDT-6.02%IMXUSDT-3.06%WIFUSDT-4.89%GRTUSDT-3.39%OPUSDT-3.00%POLUSDT-4.79%IOTAUSDT-4.19%AXSUSDT-2.25%FARTCOINUSDT-3.27%EOSUSDT-2.41%DYDXUSDT-1.79%ORDIUSDT-0.96%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
ET

Entrada Therapeutics, Inc. (TRDA)

NASDAQ • Healthcare

$6.42
-$0.69 (-9.7%)
Market closed

Last close at September 10, 2026 at 20:00 UTC

Open$6.87
Day Range$6.38 - $7.18
Avg. Volume (3M)275.2K
Market Cap$252.2M
52 Week Range
$5.02$16.45
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$898K100%
Gross Profitminus cost of goods$898K100%

Fundamentals & Financials

Revenue (TTM)
$4.6M
Net Income (TTM)
-$165.7M
EPS (TTM)
-$3.97
ROA (TTM)
-55.47%
Current Ratio
10.89

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+28.8%Q1 2026-$0.94
+10.4%Q2 2026-$0.95
-3.7%Q3 2026-$1.01
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops intracellular medicines using its proprietary EEV platform, with $25.4 million of revenue in FY2025. The platform underpins oligonucleotide, antibody, and enzyme-based therapeutic programs and frames Entrada as a drug developer rather than a commercial biopharma company.

Name
Entrada Therapeutics, Inc.
CEO
Dipal Doshi
Website
www.entradatx.com
Industry
Healthcare
Year Founded
2016
Employees
152

Today's Snapshot

AI-generated

TRDA closed 9.7% below yesterday's close, in line with a weaker sector. Shares changed hands at about a quarter more than its usual level.

Trading Volume

Above 10d avg 340.3K

448K

vs S&P 500 Today

Strong Underperformance

-9.13%

Updated: September 10, 2026 at 20:19 UTC

Technical Indicators

0 Buy2 Neutral6 Sell
TRDA is trading around 6.51 and presents a strong sell profile driven by pervasive bearish signals across moving averages and volume. Short- through long-term averages sit above the current price, CCI is deeply negative and the MACD is weak, while on-balance volume reflects selling pressure. Volatility is elevated relative to price with an ATR implying roughly a 7.3% range, and the classic pivot near 7.23 marks nearby resistance. ADX near 16 indicates limited trend strength, but the weight of momentum, moving-average alignment, and volume favors a strong sell stance. Technical takeaway: Strong Sell — multiple sell signals outweigh trend clarity.
All signals
  • EMA (5 indicators)$7.11 - $8.49
    Sell
  • RSI (14)41.32
    Neutral
  • Stochastic %K (14, 3, 3)39.54
    Neutral
  • MACD Level (12, 26)-0.01
    Sell

Peers & Related Assets

ALLOAllogene Therapeutics, Inc.
$1.76+1.7%
CAPRCapricor Therapeutics, Inc.
$8.3-3.9%
AVIRAtea Pharmaceuticals, Inc.
$5.18-1.7%
ARCTArcturus Therapeutics Holdings Inc.
$13.98-5.2%
VNDAVanda Pharmaceuticals Inc.
$5.04-4.0%
VYGRVoyager Therapeutics, Inc.
$3.19-1.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.